We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-14.86%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$134B
AUM Growth
-$30.1B
Cap. Flow
-$1.57B
Cap. Flow %
-1.17%
Top 10 Hldgs %
29.15%
Holding
6,955
New
507
Increased
2,096
Reduced
2,889
Closed
579

Sector Composition

Rank Sector Weight
1 Technology 10.07%
2 Financials 5.69%
3 Healthcare 5.49%
4 Consumer Discretionary 4.41%
5 Industrials 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZVRA icon
5551
Zevra Therapeutics
ZVRA
$575M
$4K ﹤0.01%
843
-1,293
-61% -$5.89K
OMGA
5552
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$4K ﹤0.01%
962
-1,660
-63% -$6.18K
CTV
5553
DELISTED
Innovid Corp.
CTV
$4K ﹤0.01%
+2,708
New +$11.6K
VIRX
5554
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4K ﹤0.01%
1,046
-1,307
-56% -$3.72K
PSTX
5555
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$4K ﹤0.01%
1,402
-2,355
-63% -$6.55K
GRTS
5556
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$4K ﹤0.01%
1,671
-5,732
-77% -$15.1K
ADTH
5557
DELISTED
AdTheorent Holding Co
ADTH
$4K ﹤0.01%
+1,413
New +$10.6K
THMO
5558
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$4K ﹤0.01%
+350
New +$6.9K
DMAQR
5559
CALL
DELISTED
Deep Medicine Acquisition Corp. Rights
DMAQR
$4K ﹤0.01%
36,201
IMPL
5560
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$4K ﹤0.01%
405
-331
-45% -$2.42K
CORR
5561
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$4K ﹤0.01%
1,645
-483
-23% -$1.3K
IFIN.WS
5562
CALL
DELISTED
InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share
IFIN.WS
$4K ﹤0.01%
62,501
BRQS
5563
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
$4K ﹤0.01%
200
-88
-31% -$3.45K
KLR
5564
DELISTED
Kaleyra, Inc.
KLR
$4K ﹤0.01%
529
+478
+937% +$7.01K
IMBI
5565
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$4K ﹤0.01%
+2,950
New +$8.43K
EVLO
5566
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$4K ﹤0.01%
97
-16
-14% -$742
STCN
5567
DELISTED
Steel Connect, Inc. Common Stock
STCN
$4K ﹤0.01%
+311
New +$3.7K
HZON
5568
DELISTED
Horizon Acquisition Corporation II
HZON
$4K ﹤0.01%
363
ACQRW
5569
CALL
DELISTED
Independence Holdings Corp. Warrant
ACQRW
$4K ﹤0.01%
17,438
LIONW
5570
CALL
DELISTED
Lionheart III Corp Warrant
LIONW
$4K ﹤0.01%
25,003
NVSAW
5571
CALL
DELISTED
New Vista Acquisition Corp. Warrant
NVSAW
$4K ﹤0.01%
33,334
CPARW
5572
CALL
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
$4K ﹤0.01%
19,604
SHCAW
5573
CALL
DELISTED
Spindletop Health Acquisition Corp. Warrant
SHCAW
$4K ﹤0.01%
30,407
HCIIW
5574
CALL
DELISTED
Hudson Executive Investment Corp. II Warrant
HCIIW
$4K ﹤0.01%
25,001
AKUS
5575
DELISTED
Akouos Inc
AKUS
$4K ﹤0.01%
798
-979
-55% -$3.46K

Similar funds

Citigroup's Q2 2022 Portfolio in Review

As of Q2 2022, Citigroup held 6,955 positions worth $134B, down 18% from $165B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citigroup's Q2 2022 filing shows 507 new, 2,096 increased, 2,889 reduced and 579 closed positions. Its largest new stake was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M. The largest sale was iShares Russell 2000 ETF, an estimated $565M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q2 2022 buy was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M.
  • Citigroup added most to Invesco QQQ Trust in Q2 2022, an estimated $628M increase.
  • Citigroup's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $565M.
  • Citigroup fully exited People's United Financial Inc in Q2 2022, selling an estimated $103M.
  • Citigroup's ten largest holdings make up 29% of its $134B portfolio in Q2 2022.
  • Citigroup opened 507 new positions and closed 579 in Q2 2022.
  • Citigroup's portfolio value fell 18% quarter-over-quarter to $134B.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.